Welcome to our dedicated page for FINM news (Ticker: FINM), a resource for investors and traders seeking the latest updates and insights on FINM stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect FINM's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of FINM's position in the market.
Marlin Technology Corporation (NASDAQ: FINM) announced it received a deficiency letter from NASDAQ for failing to timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2021. The delay stems from new SEC guidance regarding accounting for SPAC-related warrants, prompting a review that postponed the filing. The company plans to submit a compliance plan within 60 days and expects to file the Form 10-Q shortly, asserting that this situation does not impact its acquisition strategy or overall financial performance.
FAQ
What is the market cap of FINM (FINM)?
